CRISTY KU to Atrophy
This is a "connection" page, showing publications CRISTY KU has written about Atrophy.
Connection Strength
0.263
-
Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector. Transl Vis Sci Technol. 2024 Jun 03; 13(6):11.
Score: 0.216
-
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5. Am J Ophthalmol. 2022 08; 240:285-301.
Score: 0.046